Coverage for GLP-1 medications varies significantly by plan and diagnosis
Its main role is to neutralise free radicals , reduce cellular damage, and enhance the bodys detoxification ability
USA 111 , 1683616841 (2014)
community sources describe keeping fast-acting carbs available Organ growth gut distension and cardiomegaly possible with prolonged, high-dose use Jaw and hand growth subtle acromegaly-like changes with chronic use Cancer risk chronically elevated IGF-1 is associated with increased cancer risk in epidemiological studies Joint pain connective tissue changes, water retention Fatigue/lethargy common, especially initially Injecting before sleep community sources warn against this, as hypoglycemia during sleep is dangerous mg to Units Conversion On a standard 100-unit insulin syringe, each "unit" equals 0.01 mL (so 100 units = 1 mL)
GLP-1 therapy is generally well-tolerated, but like any prescription medication, it comes with potential side effects